Associated Papers
Unveiling a rare BRAF mutation in minimally invasive follicular thyroid carcinoma: A case report.
Lee PS et al.
Medicine, 2024
Integrated molecular and clinical analysis of BRAF-mutant glioma in adults.
Schreck KC et al.
Npj Precision Oncology, 2023
Finding driver mutations in cancer: Elucidating the role of background mutational processes.
Brown AL et al.
Plos Computational Biology, 2019
31034466 (PubMed )
Supplement: pcbi.1006981.s010.xlsx › final_benchmark
Benchmarking mutation effect prediction algorithms using functionally validated cancer-related missense mutations.
Martelotto LG et al.
Genome Biology, 2014
25348012 (PubMed )
Supplement: 13059_2014_484_MOESM2_ESM.xlsx › Additional_file_2
Functional characterization of the novel BRAF complex mutation, BRAF(V600delinsYM) , identified in papillary thyroid carcinoma.
Matsuse M et al.
International Journal of Cancer, 2013
Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma.
Santarpia L et al.
Cancer, 2010
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif.
Moretti S et al.
Biochimica Et Biophysica Acta, 2009
Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinoma.
De Falco V et al.
The Journal of Clinical Endocrinology and Metabolism, 2008
Clinical prognosis in BRAF-mutated PTC.
Puxeddu E et al.
Arquivos Brasileiros De Endocrinologia E Metabologia, 2007
Significance of BRAF mutations in papillary thyroid carcinoma: prognostic and therapeutic implications.
Groussin L et al.
Nature Clinical Practice. Endocrinology & Metabolism, 2006
PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
Castro P et al.
The Journal of Clinical Endocrinology and Metabolism, 2006
Select a paper to view details